Optinose Reports Second Quarter 2023 Financial Results and Operational UpdatesGlobeNewsWire • 08/10/23
Optinose Announces Preliminary Second Quarter 2023 XHANCE Net Revenue of $19.5 MillionGlobeNewsWire • 07/27/23
Optinose Reports First Quarter 2023 Financial Results and Operational UpdatesGlobeNewsWire • 05/11/23
Optinose Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Operational HighlightsGlobeNewsWire • 03/07/23
Optinose Announces Corporate Updates and Presentation at the 34th Annual Piper Sandler Healthcare ConferenceGlobeNewsWire • 11/30/22
Optinose Announces ReOpen2 Presentation at the American College of Asthma, Allergy, and Immunology (ACAAI) 2022 Annual Scientific MeetingGlobeNewsWire • 11/09/22
Optinose Announces ReOpen1 Abstract Selected for Presentation at the American Rhinologic Society Annual MeetingGlobeNewsWire • 09/06/22
OptiNose, Inc. (OPTN) CEO Peter Miller on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/13/22